What You Need to Know About Puma Biotech's 25% Slide By: Benzinga via Benzinga January 24, 2018 at 09:15 AM EST Shares of Puma Biotechnology Inc (NASDAQ: PBYI), a development stage biotech company focusing on cancer treatment, are down over 25 ... Read More >> Related Stocks: Puma Biotechnology Roche Holding AG Basel American Depositary Shares